Resultats de la cerca - Itzhak H. Rachmut
- Mostrar 1 - 2 resultats de 2
-
1
-
2
Mutant KRAS is a druggable target for pancreatic cancer per Elina Zorde Khvalevsky, Racheli Gabai, Itzhak H. Rachmut, E. Philip Horwitz, Zivia Brunschwig, Ariel Orbach, Adva Shemi, Talia Golan, Abraham J. Domb, Eylon Yavin, Hilla Giladi, Ludmila Rivkin, Alina Simerzin, Rami Eliakim, Abed Khalaileh, Ayala Hubert, Maor Lahav, Yael Kopelman, Eran Goldin, Alan Dancour, Yael Hants, Sagit Arbel-Alon, Rinat Abramovitch, Amotz Shemi, Eithan Galun
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer research
Gene
Genetics
Internal medicine
Medicine
Adenocarcinoma
Biochemistry
Biotechnology
Cancer
Cell
Cell biology
Cell culture
Cell cycle
Cell fate determination
Cellular differentiation
Chemistry
Colorectal cancer
Druggability
Endocrinology
Gene silencing
In vivo
Insulin
Islet
KRAS
Oncogene
PDX1
Pancreas
Pancreatic cancer
Pharmacology